{
  "id": [
    "32510562"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "32510562"
  ],
  "pmcid": [
    "PMC7314002"
  ],
  "doi": [
    "10.1093/femspd/ftaa025"
  ],
  "title": [
    "Long-term and herd immunity against SARS-CoV-2: implications from current and past knowledge."
  ],
  "authorString": [
    "Papachristodoulou E, Kakoullis L, Parperis K, Panos G."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Papachristodoulou E"
          ],
          "firstName": [
            "Eleni"
          ],
          "lastName": [
            "Papachristodoulou"
          ],
          "initials": [
            "E"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine, University of Cyprus Medical School, Nicosia, Cyprus."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Kakoullis L"
          ],
          "firstName": [
            "Loukas"
          ],
          "lastName": [
            "Kakoullis"
          ],
          "initials": [
            "L"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine, Nicosia General Hospital, Nicosia, Cyprus.",
                "Department of Respiratory Medicine, University of Patras General Hospital, Patras, Greece."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Parperis K"
          ],
          "firstName": [
            "Konstantinos"
          ],
          "lastName": [
            "Parperis"
          ],
          "initials": [
            "K"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine, University of Cyprus Medical School, Nicosia, Cyprus.",
                "Department of Medicine, Division of Rheumatology, University of Arizona College of Medicine, Phoenix, Arizona, USA."
              ]
            }
          ]
        },
        {
          "fullName": [
            "Panos G"
          ],
          "firstName": [
            "George"
          ],
          "lastName": [
            "Panos"
          ],
          "initials": [
            "G"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                "Department of Internal Medicine, University of Cyprus Medical School, Nicosia, Cyprus.",
                "Department of Internal Medicine, Section of Infectious Diseases, University of Patras General Hospital, Patras, Greece."
              ]
            }
          ]
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "altmetrics"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "3"
      ],
      "volume": [
        "78"
      ],
      "journalIssueId": [
        "2943868"
      ],
      "dateOfPublication": [
        "2020 Apr"
      ],
      "monthOfPublication": [
        "4"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-04-01"
      ],
      "journal": [
        {
          "title": [
            "Pathogens and disease"
          ],
          "ISOAbbreviation": [
            "Pathog Dis"
          ],
          "medlineAbbreviation": [
            "Pathog Dis"
          ],
          "NLMid": [
            "101595366"
          ],
          "ISSN": [
            "2049-632X"
          ],
          "ESSN": [
            "2049-632X"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "abstractText": [
    "Effective herd immunity against SARS-CoV-2 will be determined on many factors: the percentage of the immune population, the length and effectiveness of the immune response and the stability of the viral epitopes. The required percentage of immune individuals has been estimated to be 50-66% of the population which, given the current infection rates, will take long to be achieved. Furthermore, data from SARS-CoV suggest that the duration of immunity may not be sufficiently significant, while the immunity response against SARS-CoV-2 may not be efficiently effective in all patients, as relapses have already been reported. In addition, the development of mutant strains, which has already been documented, can cause the reemergence of the epidemic. In conclusion, the development of an effective vaccine is an urgent necessity, as long-term natural immunity to SARS-CoV-2 may not be sufficient for the control of the current and future outbreaks."
  ],
  "affiliation": [
    "Department of Internal Medicine, University of Cyprus Medical School, Nicosia, Cyprus."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pneumonia, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Coronavirus Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Immunity, Herd"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Time Factors"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Pandemics"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Betacoronavirus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IM"
                  ],
                  "qualifierName": [
                    "immunology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Antibodies",
        "Quarantine",
        "Coronavirus",
        "Pandemic",
        "outbreak",
        "Covid-19"
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1093/femspd/ftaa025"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7314002"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7314002?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1093/femspd/ftaa025"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "N"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2020-06-25"
  ],
  "dateOfCreation": [
    "2020-06-09"
  ],
  "firstIndexDate": [
    "2020-06-08"
  ],
  "fullTextReceivedDate": [
    "2020-06-29"
  ],
  "dateOfRevision": [
    "2020-06-26"
  ],
  "firstPublicationDate": [
    "2020-04-01"
  ]
}